Neurobiology of schizophrenia: Search for the elusive correlation with symptoms

Frontiers in Human Neuroscience

Volumn , Issue MAY 2012, 2012, Pages 1-6

  Mathalon, Daniel H ^a,b   Ford, Judith M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Correlation; Negative symptoms; Neurobiology; Positive symptoms; Rating scales; Reliability; Schizophrenia; Validity

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; CASE CONTROL STUDY; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; EVENT RELATED POTENTIAL; HUMAN; HYPOTHESIS; INTERRATER RELIABILITY; INTERVIEW; METHODOLOGY; NEUROBIOLOGY; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SAMPLE SIZE; SCALE FOR THE ASSESSMENT OF NEGATICE SYMPTOMS; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOPHRENIA; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; VALIDITY;

EID: 84864088511     PISSN: 16625161     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2012.00136     Document Type: Article

References (43)

1. Adler, C. M., Malhotra, A. K., Elman, I., Goldberg, T., Egan, M., Pickar, D., and Breier, A. (1999). Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry 156, 1646-1649.
2. Amann, L. C., Gandal, M. J., Halene, T. B., Ehrlichman, R. S., White, S. L., McCarren, H. S., and Siegel, S. J. (2010). Mouse behavioral endophe-notypes for schizophrenia. Brain Res. Bull. 83, 147-161.
3. Anastasi, A. (1982). Psychological Testing. New York: MacMillan.
4. Andreasen, N. C. (1983). The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa.
5. Andreasen, N. C. (1984). Scale for the Assessment of Positive Symptoms. Iowa City, IA: University of Iowa.
6. Ben-Zeev, D., Ellington, K., Swendsen, J., and Granholm, E. (2011). Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: a computerized experience sampling study. Schizophr. Bull. 37, 1248-1256.
7. Csikszentmihalyi, M., and Larson, R. (1987). Validity and reliability of the experience-sampling method. J. Nerv. Ment. Dis. 175, 526-536.
8. de Klerk, G. (2008). "Classical test theory (CTT)," in Online Readings in Testing and Assessment, International Test Commission, eds M. Born, C. D. Foxcroft, and R. Butter. Available at: http://www.intestcom.org/Publications/ORTA.php
9. Debruille, J. B., Kumar, N., Saheb, D., Chintoh, A., Gharghi, D., Lion-net, C., and King, S. (2007). Delusions and processing of discrepant information: an event-related brain potential study. Schizophr. Res. 89, 261-277.
10. Drake, R., Haddock, G., Tarrier, N., Bentall, R., and Lewis, S. (2007). The psychotic symptom rating scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr. Res. 89, 119-122.
11. Ehrlichman, R. S., Luminais, S. N., White, S. L., Rudnick, N. D., Ma, N., Dow, H. C., Kreibich, A. S., Abel, T., Brodkin, E. S., Hahn, C. G., and Siegel, S. J. (2009). Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res. 1294, 116-127.
12. Epstein, S. (1984). A procedural note on the measurement of broad dispositions. J. Pers. 52, 318-325.
13. Epstein, S. (1997). This I have learned from over 40 years of personality research. J. Pers. 65, 3-32.
14. Epstein, S., and O'Brien, E. J. (1985). The person-situation debate in historical and current perspective. Psychol. Bull. 98, 513-537.
15. Epstein, S., Pacini, R., Denes-Raj, V., and Heier, H. (1996). Individual differences in intuitive-experiential and analytical-rational thinking styles. J. Pers. Soc. Psychol. 71, 390-405.
16. Freedman, R., Adler, L. E., Myles-Worsley, M., Nagamoto, H. T., Miller, C., Kisley, M., McRae, K., Cawthra, E., and Waldo, M. (1996). Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch. Gen. Psychiatry 53, 1114-1121.
17. Goldman-Rakic, P. (1994). Working memory dysfunction in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 6, 348-357.
18. Goldman-Rakic, P. (1999). The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 46, 650-661.
19. Hoffman, R., Boutros, N., Hu, S., Berman, R., Krystal, J., and Char-ney, D. (2000). Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 355, 1073-1075.
20. Holroyd, C., and Coles, M.G.H. (2002). The neural basis of human error processing: reinforcement learning, dopamine and the error-related negativity. Psychol. Rev. 109, 679-709.
21. Javitt, D. C., Steinschneider, M., Schroeder, C. E., and Arezzo, J. C. (1996). Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 93, 11962-11967.
22. Kay, S., Fiszbein, A., and Opler, L. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261-276.
23. Kopp, B., and Rist, F. (1999). An event-related brain potential substrate of disturbed response monitoring in paranoid schizophrenic patients. J. Abnorm. Psychol. 108, 337-346.
24. Krystal, J. H., D'Souza, D. C., Math-alon, D., Perry, E., Belger, A., and Hoffman, R. (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl.) 169, 215-233.
25. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Brem-ner, J. D., Heninger, G. R., Bowers, M. B. Jr., and Charney, D. S. (1994). Sub-anesthetic effects of the noncompet-itive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199-214.
26. Lahti, A. C., Koffel, B., LaPorte, D., and Tamminga, C. A. (1995). Sub-anesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 9-19.
27. Mathalon, D. H., Fedor, M., Faustman, W. O., Gray, M., Askari, N., and Ford, J. M. (2002). Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J. Abnorm. Psychol. 111, 22-41.
28. Mathalon, D. H., Ford, J. M., and Pfef-ferbaum, A. (2000). Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol. Psychiatry 47, 434-449.
29. Mathalon, D. H., Sullivan, E. V., Lim, K. O., and Pfefferbaum, A. (2001). Progressive brain volume changes and the clinical course of schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 58, 148-157.
30. McGlashan, T. H. (1988). A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 14, 515-542.
31. McGlashan, T. H., and Fenton, W. S. (1992). The positive-negative distinction in schizophrenia - review of natural history validators. Arch. Gen. Psychiatry 49, 63-72.
32. Metzger, K. L., Maxwell, C. R., Liang, Y., and Siegel, S. J. (2007). Effects of nicotine vary across two auditory evoked potentials in the mouse. Biol. Psychiatry 61, 23-30.
33. Moore, J. W., Turner, D. C., Corlett, P. R., Arana, F. S., Morgan, H. L., Absalom, A. R., Adapa, R., de Wit, S., Everitt, J. C., Gardner, J. M., Pig-ott, J. S., Haggard, P., and Fletcher, P. C. (2011). Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cogn. Neuropsychiatry 1-18.
34. Morris, S. E., Holroyd, C. B., Mann-Wrobel, M. C., and Gold, J. M. (2011). Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Front. Hum. Neurosci. 5:123. doi:10.3389/fnhum.2011.00123
35. Neill, E., Rossell, S. L., McDonald, S., Joshua, N., Jansen, N., and Morgan, C. J. (2011). Using ketamine to model semantic deficits in schizophrenia. J. Clin. Psychopharmacol. 31, 690-697.
36. Oorschot, M., Lataster, T., Thewissen, V., Wichers, M., and Myin-Germeys, I. (2012). Mobile assessment in schizophrenia: a data-driven momentary approach. Schizophr. Bull. 38, 405-413.
37. Overall, J. E., and Gorham, D. R. (1962). The brief psychiatric rating scale. Psychol. Rep. 10, 799-812.
38. Overall, J. E., and Gorham, D. R. (1988). The brief psychiatric rating scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol. Bull. 24, 97-99.
39. Perlstein, W. M., Carter, C. S., Noll, D. C., and Cohen, J. D. (2001). Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. A. J. Psychiatry 158, 1105-1113.
40. Slotema, C. W., Blom, J. D., Hoek, H. W., and Sommer, I. E. (2010). Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J. Clin. Psychiatry 71, 873-884.
41. Swendsen, J., Ben-Zeev, D., and Granholm, E. (2011). Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Am. J. Psychiatry 168, 202-209.
42. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., and Javitt, D. C. (2000). Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57, 1139-1147.
43. Wiggins, J. S. (1980). Personality and Prediction: Principles of Personality Assessment. Reading, MA: Addison-Wesley Publishing Company.